Company: VEEAW
Filing Date: 2025-07-07
Form Type: DRS
Source: 0001213900-25-061586
Chunk: 91

Company: VEEA INC.
Filing Date: 2025-07-07
Form: DRS
Chunk 91
---
 stock underlying outstanding options, of which 3,743,744 are fully vested and exercisable; |

| ● | 900,614 shares of common stock underlying outstanding RSUs, of which 466,430 are fully vested and exercisable |

| ● | 624,350 shares available for future issuance under the Veea Inc. 2024 Incentive Award Plan. |

| ● | the shares of common stock issuable upon exercise of the Investor Warrants issued in this offering. |

Except as otherwise indicated,
the information in this prospectus assumes no exercise of any existing options or exercise of any existing warrants.

The discussion and table above
assume no exercise of the common warrants. To the extent that the Investor Warrants are exercised, you may experience further dilution.
In addition, we may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have
sufficient funds for our current or future operating plans. To the extent that additional capital is raised through the sale of equity
or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders.

<div align='center'>46

CAPITALIZATION</div>

The following table sets forth
our cash and cash equivalents and capitalization as of March 31, 2025:

| ● | on an actual basis; |

| ● | on an as adjusted basis to give effect to 175,000 shares of common stock issued under the Company’s ELOC Purchase Agreement for gross proceeds of $242,340 million subsequent to March 31, 2025; |

| ● | on a pro forma as adjusted basis to give further effect to the issuance and sale of [__] shares of our common stock and accompanying warrants in this offering at an assumed offering price of $[__] per share, which was the closing price of our common stock as reported on Nasdaq on [__], 2025, after deducting the placement agent fees and estimated offering expenses payable by us, and assuming no sale of pre-funded warrants and no exercise of Warrants. |

Our capitalization following
the closing of this offering will be adjusted based on the actual public offering price and other terms of this offering determined at
pricing. You should read this table in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results
of Operations” and our financial statements and related notes included elsewhere in this prospectus.

|                                                                                                                                                                                                                                                                      |     | Actual |      |     | Pro Forma |      |     | Pro